Publications

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

Bejon, P; Ogada, E; Mwangi, T; MILLIGAN, P; Lang, T; Fegan, G; Gilbert, SC; Peshu, N; Marsh, K; Hill, AV S;

2007

PloS one, (2007).2 8 10.1371/journal.pone.0000707.

Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.

Akumu, AO; English, M; SCOTT, JA G; GRIFFITHS, UK;

2007

Bulletin of the World Health Organization, (2007).85 7 10.2471/blt.06.034686.

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.

Osier, FH A; Polley, SD; Mwangi, T; Lowe, B; CONWAY, DJ; Marsh, K;

2007

Parasite immunology, (2007).29 8 10.1111/j.1365-3024.2007.00951.x.

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

Stephens, DS; GREENWOOD, B; Brandtzaeg, P;

2007

Lancet, (2007).369 9580 10.1016/S0140-6736(07)61016-2.

Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.

Moss, WJ; SCOTT, S; Mugala, N; Ndhlovu, Z; Beeler, JA; Audet, SA; Ngala, M; Mwangala, S; Nkonga-Mwangilwa, C; Ryon, JJ; Monze, M; Kasolo, F; Quinn, TC; COUSENS, S; Griffin, DE; Cutts, FT;

2007

The Journal of infectious diseases, (2007).196 3 10.1086/519169.

Validation of influenza and pneumococcal vaccine status in adults based on self-report.

MANGTANI, P; Shah, A; Roberts, JA;

2006

Epidemiology and infection, (2006).135 1 10.1017/S0950268806006479.

Economic evaluations of travellers' vaccinations.

Roberts, J; MANGTANI, P;

2006

In: Travellers Vaccines , BC Decker (Ontario) (2006).

A vision of a world without polio: the OPV cessation strategy.

HEYMANN, DL; Sutter, RW; Aylward, RB;

2006

Biologicals, (2006).34 2 10.1016/j.biologicals.2006.03.005.

Mass vaccination. When and Why?.

HEYMANN, DL; Aylward, RB;

2006

Mass Vaccination: Global Aspects - Progress and Obstacles , Springer (2006). 10.1007/3-540-36583-4_1.

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.

Enosse, S; Dobaño, C; Quelhas, D; Aponte, JJ; Lievens, M; Leach, A; Sacarlal, J; GREENWOOD, B; Milman, J; Dubovsky, F; Cohen, J; Thompson, R; Ballou, WR; Alonso, PL; CONWAY, DJ; SUTHERLAND, CJ;

2006

PLoS clinical trials, (2006).1 1 10.1371/journal.pctr.0010005.